MuukTest
It's clear that enhancing your testing efforts could help identify bugs sooner, yet effective QA testing often demands significant time, effort, and resources. With MuukTest, engineering teams can achieve up to 95% coverage of end-to-end tests in a mere three months.
Our team of QA specialists is dedicated to creating, overseeing, maintaining, and updating E2E tests on the MuukTest Platform for your web, API, and mobile applications with unparalleled speed. After reaching 100% regression coverage within just eight weeks, we initiate exploratory and negative testing to discover bugs and further elevate your testing coverage. By managing your testing frameworks, scripts, libraries, and maintenance, we significantly reduce the time you spend on development.
Additionally, we take a proactive approach to identify flaky tests and false results, ensuring that your testing process remains accurate. Consistently conducting early and frequent tests enables you to catch errors during the initial phases of the development lifecycle, thus minimizing the burden of technical debt in the future. By streamlining your testing processes, you can improve overall product quality and enhance team productivity.
Learn more
Stack AI
AI agents are designed to engage with users, answer inquiries, and accomplish tasks by leveraging data and APIs. These intelligent systems can provide responses, condense information, and derive insights from extensive documents. They also facilitate the transfer of styles, formats, tags, and summaries between various documents and data sources. Developer teams utilize Stack AI to streamline customer support, manage document workflows, qualify potential leads, and navigate extensive data libraries. With just one click, users can experiment with various LLM architectures and prompts, allowing for a tailored experience. Additionally, you can gather data, conduct fine-tuning tasks, and create the most suitable LLM tailored for your specific product needs. Our platform hosts your workflows through APIs, ensuring that your users have immediate access to AI capabilities. Furthermore, you can evaluate the fine-tuning services provided by different LLM vendors, helping you make informed decisions about your AI solutions. This flexibility enhances the overall efficiency and effectiveness of integrating AI into diverse applications.
Learn more
SYNTHIA Retrosynthesis Software
SYNTHIA™ Retrosynthesis software, created through the collaboration of computer scientists and chemists, empowers researchers to swiftly explore new and established pathways for target molecules. This tool enables efficient scanning of numerous pathways, helping to pinpoint the most suitable options tailored to specific requirements. With advanced visualization and filtering capabilities, users can uncover the most economical route to synthesize their desired molecule. The platform also allows for the customization of search parameters, enabling the user to either exclude or emphasize particular reactions, reagents, or molecular classes. Additionally, it presents innovative and distinctive synthetic routes to construct the target compound. Users can effortlessly generate a list of commercially available starting materials needed for their synthesis projects. Furthermore, the ISO/IEC 27001 Information Security Certification ensures the utmost confidentiality, integrity, and security of all data processed within the software, providing peace of mind to its users. This commitment to data protection reinforces the software's value in the scientific community.
Learn more
The Galen Platform
Ibex Medical Analytics leads the way in the application of AI technology for cancer diagnostics within pathology. Our multidisciplinary team consists of entrepreneurs, software engineers, data scientists, and healthcare professionals who share a common goal: to transform cancer diagnostics through artificial intelligence, ultimately improving the quality of patient care. As the number of tests conducted each year increases, pathologists encounter considerable challenges in providing accurate and timely evaluations. To tackle these issues, Ibex utilizes AI to develop clinical-grade solutions designed to detect cancer with a level of precision comparable to that of human pathologists. The Galen Platform uses sophisticated algorithms to analyze imaging, identify and categorize cancer in biopsy samples, and emphasize other clinically relevant findings, which aids pathologists in reducing diagnostic mistakes and enhancing their workflow efficiency. In particular, Ibex's Galen™ Prostate and Galen™ Breast tools are groundbreaking AI-driven cancer detection solutions that have been integrated into standard clinical practice in pathology laboratories, demonstrating proven effectiveness in identifying cancer cases that were previously overlooked. As we persist in our quest for progress, our dedication to advancing cancer detection and improving patient outcomes continues to be resolute and inspiring for the entire medical community.
Learn more
